Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases
Open Access
- 27 October 2011
- journal article
- review article
- Published by Hindawi Limited in Journal of Immunology Research
- Vol. 2012, 1-14
- https://doi.org/10.1155/2012/941346
Abstract
Systemic autoimmune and rheumatic diseases (SAIRDs) are thought to develop due to the failure of autoimmune regulation and tolerance. Current therapies, such as biologics, have improved the clinical results of SAIRDs; however, they are not curative treatments. Recently, new discoveries have been made in immune tolerance and inflammation, such as tolerogenic dendritic cells, regulatory T and B cells, Th 17 cells, inflammatory and tolerogenic cytokines, and intracellular signaling pathways. They lay the foundation for the next generation of the therapies beyond the currently used biologic therapies. New drugs should target the core processes involved in disease mechanisms with the aim to attain complete cure combined with safety and low costs compared to the biologic agents. Re-establishment of autoimmune regulation and tolerance in SAIRDs by the end of the current decade should be the final and realistic target.Keywords
Funding Information
- Japan Society for the Promotion of Science (21-8117)
This publication has 155 references indexed in Scilit:
- How Tolerogenic Dendritic Cells Induce Regulatory T CellsPublished by Elsevier BV ,2010
- Most common single‐nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African AmericansArthritis & Rheumatism, 2010
- Rheumatoid arthritis risk allele PTPRC is also associated with response to anti–tumor necrosis factor α therapyArthritis & Rheumatism, 2010
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation studyArthritis & Rheumatism, 2010
- Novel targeted therapies for autoimmunityCurrent Opinion in Immunology, 2009
- T cell receptor signaling induced by an analog peptide of type II collagen requires activation of SykClinical Immunology, 2009
- Mouse dendritic cells matured by ingestion of apoptotic blebs induce T cells to produce interleukin‐17Arthritis & Rheumatism, 2009
- Gene–environment interaction between the DRB1 shared epitope and smoking in the risk of anti–citrullinated protein antibody–positive rheumatoid arthritis: All alleles are importantArthritis & Rheumatism, 2009
- Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patientsArthritis & Rheumatism, 2008
- Toll-like Receptor 7 and TLR9 Dictate Autoantibody Specificity and Have Opposing Inflammatory and Regulatory Roles in a Murine Model of LupusImmunity, 2006